Overview
With a research background heavily weighted in drug delivery systems in the treatment of cancer, the focus of my work has shifted to vaccination delivery methods as potential anticancer strategies. The goal of my current funding is to identify and develop a vaccine strategy delivered via the intranasal (IN) route that induces a cytotoxic T lymphocyte (CTL) response adequate for the protection/prevention of metastatic lung cancer.
I am currently working under the mentorship of Dr. Herman Staats, and in addition to the cancer immunotherapy studies, I have a strong interest in mucosal immunization and maternal immunization studies, specifically in the rabbit model.
Current Appointments & Affiliations
Assistant Professor of Pathology
·
2022 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2020 - Present
Duke Cancer Institute,
Institutes and Centers
Education, Training & Certifications
North Carolina State University ·
2017
D.V.M.
Duke University ·
2013
Ph.D.